Jean‐Marc Herbert
Sanofi (France)(FR)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Antiplatelet Therapy and Cardiovascular Diseases, Platelet Disorders and Treatments, Venous Thromboembolism Diagnosis and Management, Protease and Inhibitor Mechanisms
Most-Cited Works
- → Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions(2001)1,662 cited
- → Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis(1999)1,278 cited
- → Chelerythrine is a potent and specific inhibitor of protein kinase C(1990)1,206 cited
- → Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1(2003)764 cited
- → Identification and Biological Activity of the Active Metabolite of Clopidogrel(2000)744 cited
- → Structure and Stereochemistry of the Active Metabolite of Clopidogrel(2002)457 cited
- → Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis(2001)436 cited
- → The Lectin-like Domain of Thrombomodulin Confers Protection from Neutrophil-mediated Tissue Damage by Suppressing Adhesion Molecule Expression via Nuclear Factor κB and Mitogen-activated Protein Kinase Pathways(2002)349 cited
- → Synthesis of thrombin-inhibiting heparin mimetics without side effects(1999)321 cited
- → Clopidogrel and Ticlopidine: P2Y12Adenosine Diphosphate-Receptor Antagonists for the Prevention of Atherothrombosis(2005)320 cited